Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics

27 Feb 2021

Abstract excerpt

The epidemic of diabetes mellitus (DM) necessitates the development of novel therapeutic and preventative strategies to attenuate complications of this debilitating disease. Diabetic cardiomyopathy (DCM) is a frequent disorder affecting individuals diagnosed with DM characterized by left ventricular hypertrophy, diastolic and systolic dysfunction and myocardial fibrosis in the absence of other heart diseases....

Topics

Join the communities discussing this publication.

Cancer-related molecular mechanisms research
Cardiovascular Function and Risk Factors
Circular RNAs in diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33639953
DOI: 10.1186/s12933-021-01245-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeuticsPMID 33639953Read ↗

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAsSemantic proximity Read ↗

Role of microRNAs in the pathogenesis of diabetic cardiomyopathySemantic proximity Read ↗

MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathySemantic proximity Read ↗

The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathySemantic proximity Read ↗

Pathogenesis of Diabetic Cardiomyopathy and Role of miRNASemantic proximity Read ↗

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic CardiomyopathySemantic proximity Read ↗

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy.Semantic proximity Read ↗

Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological StrategiesSemantic proximity Read ↗

Molecular Mechanisms and Epigenetic Regulation in Diabetic CardiomyopathySemantic proximity Read ↗

Established and Emerging Roles of Epigenetic Regulation in Diabetic CardiomyopathySemantic proximity Read ↗

LncRNA as a regulator in the development of diabetic complicationsSemantic proximity Read ↗

MicroRNAs and Cardiovascular Disease in Diabetes Mellitus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.